April 01, 2020 Akero’s success gives a new Nash mechanism hope Before Covid-19 came along investors were looking to several Nash catalysts in 2020, and yesterday Akero delivered on one of these.
May 08, 2019 Astra and Daiichi lay out their plan for a better Herceptin The companies’ DS-8201 succeeds in breast cancer patients who had failed Kadcyla, and will go before the regulators later this year.
